These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 1475033

  • 1. Possible role of cholecystokinin-A receptors in regulation of thyrotropin (TSH) secretion in male rats.
    Männistö PT, Peuranen E, Harro J, Vasar E.
    Neuropeptides; 1992 Dec; 23(4):251-8. PubMed ID: 1475033
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.
    Vasar E, Harro J, Lang A, Pôld A, Soosaar A.
    Psychopharmacology (Berl); 1991 Dec; 105(3):393-9. PubMed ID: 1798834
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
    Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN.
    Proc Natl Acad Sci U S A; 1991 Feb 15; 88(4):1130-3. PubMed ID: 1996314
    [Abstract] [Full Text] [Related]

  • 9. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
    Niederau M, Niederau C, Strohmeyer G, Grendell JH.
    Am J Physiol; 1989 Jan 15; 256(1 Pt 1):G150-7. PubMed ID: 2463767
    [Abstract] [Full Text] [Related]

  • 10. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
    Dembinski A, Jaworek J, Konturek PK, Konturek SJ, Warzecha Z.
    J Physiol; 1989 Apr 15; 411():419-35. PubMed ID: 2614728
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    Millington WR, Mueller GP, Lavigne GJ.
    J Pharmacol Exp Ther; 1992 May 15; 261(2):454-61. PubMed ID: 1578360
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
    Pu SF, Han JS.
    Sheng Li Xue Bao; 1993 Oct 15; 45(5):470-8. PubMed ID: 8146670
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.
    Vasar E, Lang A, Harro J, Bourin M, Bradwejn J.
    Neuropharmacology; 1994 Jun 15; 33(6):729-35. PubMed ID: 7936110
    [Abstract] [Full Text] [Related]

  • 17. Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry.
    Reum T, Schäfer U, Marsden CA, Fink H, Morgenstern R.
    Neuropeptides; 1997 Feb 15; 31(1):82-8. PubMed ID: 9574843
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.